1Carter SK. Clinical strategy for the development of angiogenesis inhibitors . Oncologist, 2000;5 Suppl 1:51-54.
2Dong JT, Lamb PW, Rinker-Schaeffer CW, et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science, 1995;268(5212):884-886.
6ANAN K,MORISAKI T,KATAON M,et al.Vascular endothelial growth factor and platelet derived growth factor are potential angiogenic and metastatic factors in human breast cancer[J].Surgery,1996,119 (3):333.
9Kamalati T, Niranjan B, Yant J, et al. HGF/SF in mammary epithelial gowth and morphogenesis:in vitro and in vivo models[J] .J Mammary Gland Biol Neoplasia, 1999,4(1):69-77.
10Webb CP, Van Aelst L, Wigler MH, et al. Signaling pathways in Rasmediated tumorigenicity and metastasis[J]. Proc Natl Acad Sci USA,1998,95 (15): 8773-8778.
9Bauer R.Quality criteria and phytopharmaceutical:Can acceptable drug standards be achieved?[J].Drug Infor J,1998,32:101-110.
10Lazarowych N.Use of fingerpriting and marker compounds for identification and standardization of botanical drugs strategies for applying pharmaceutical HPLCanalysis to herbal products[J].Drug Infor J,1998,32:497-512.
